Hyperthermia Enhances Doxorubicin Therapeutic Efficacy against A375 and MNT-1 Melanoma Cells
Melanoma is the deadliest form of skin cancer, and its incidence has alarmingly increased in the last few decades, creating a need for novel treatment approaches. Thus, we evaluated the combinatorial effect of doxorubicin (DOX) and hyperthermia on A375 and MNT-1 human melanoma cell lines. Cells were...
Main Authors: | Diana Salvador, Verónica Bastos, Helena Oliveira |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/1/35 |
Similar Items
-
Combined Therapy with Dacarbazine and Hyperthermia Induces Cytotoxicity in A375 and MNT-1 Melanoma Cells
by: Diana Salvador, et al.
Published: (2022-03-01) -
Liposome-Fe3 O4-Doxorubicin Mediated Treatment of Melanoma Tumors
by: Azalia Azlegini, et al.
Published: (2023-03-01) -
Hybrid System for Local Drug Delivery and Magnetic Hyperthermia Based on SPIONs Loaded with Doxorubicin and Epirubicin
by: Dorota Nieciecka, et al.
Published: (2021-04-01) -
Biomimetic Magnetite Nanoparticles as Targeted Drug Nanocarriers and Mediators of Hyperthermia in an Experimental Cancer Model
by: Francesca Oltolina, et al.
Published: (2020-09-01) -
Increased uptake of doxorubicin by cells undergoing heat stress does not explain its synergistic cytotoxicity with hyperthermia
by: Anirudh Sharma, et al.
Published: (2019-01-01)